The Escalating Health Crisis for Gaza's Diabetes Community

The ongoing conflict and associated restrictions in the Gaza Strip have created a perilous environment for individuals living with diabetes. For many, the daily management of their condition has transformed into a critical struggle for survival, marked by the scarcity of vital medications and monitoring equipment. This situation poses significant and often life-threatening risks, leading to a surge in severe health complications among the affected population.

Hamza al-Ghazali, a 20-year-old Type 1 diabetes patient residing in Gaza City's Zeitoun neighborhood, exemplifies the profound difficulties faced. His routine now includes a constant and often fruitless search for insulin pens, a quest that has become a regular feature of his life since the conflict began in October 2023. The tightening of restrictions on the entry of medical supplies into Gaza has exacerbated these challenges, making access to essential treatment an increasingly arduous task.

The Struggle for Essential Supplies and Soaring Costs

Before the conflict, Hamza's diabetes management was relatively stable. Insulin pens were readily available at prices ranging from 25 to 35 shekels ($8.5 to $12). He recalls being a familiar face at local pharmacies due to his regular purchases. However, the war has drastically altered this reality. The price of a single insulin pen has skyrocketed to between 75 and 100 shekels ($25 and $34). Given his need for six to seven pens monthly, Hamza is now compelled to meticulously ration each pen, extending its use far beyond recommended guidelines.

The broader suffering of diabetes patients in Gaza is intrinsically linked to the restrictions on medical imports. These measures have resulted in a severe deficit of insulin, glucose meters, and test strips. Hamza notes that this scarcity has led to an unstable medical market where, in some instances, medicines of questionable quality or those stored improperly for extended periods become the only available options. This raises significant concerns about their efficacy and safety, particularly when no alternatives exist.

Navigating Nutritional Challenges and Constant Fear

A year ago, when a blockade on food entry led to widespread famine in northern Gaza, Hamza faced a dual challenge: not only securing enough food but also balancing his limited insulin supply with whatever sustenance he could find. An excess of food without adequate insulin could lead to dangerously high blood sugar levels, while reducing food intake out of fear of insulin depletion could result in severe, potentially fatal hypoglycemia (low blood sugar).

Hamza recounted the constant dread during the shelling in northern Gaza. "We were under siege. If the house was bombed, I might survive under the rubble, but die from low blood sugar. And if I ate without insulin, my sugar could rise dangerously. I was living between two fears all the time." This fear extended beyond insulin to the potential loss of glucose meters and test strips, which are crucial for daily monitoring. Whenever forced to evacuate, his "diabetes bag" was always the first item he secured.

The Crisis of Inadequate Monitoring Equipment

The shortage of glucose test strips has severely hindered Hamza's ability, and that of countless others, to regularly monitor blood sugar levels. This forces patients to rely solely on physical symptoms, a dangerously unreliable method. While a glucose meter itself might cost between 250 and 300 shekels ($85 and $120), the core issue lies in the scarcity of test strips. Without these, the device is rendered useless, sometimes forcing patients to repeatedly purchase new meters in a desperate attempt to find functional strips.

Hamza estimates that over 80 percent of diabetes patients in certain areas are unable to perform regular blood sugar tests, a situation he describes as a "medical disaster." This transforms diabetes management into a daily guessing game, significantly increasing the risk of complications. According to data from the Palestinian Ministry of Health in Gaza, between 70,000 and 80,000 diabetes patients in the enclave are at heightened risk due to the critical shortages of insulin and test strips, compounded by the collapse of medical follow-up services and poor nutrition.

Expert Warnings on Deteriorating Conditions

Dr. Adli al-Ghouti, an endocrinology and diabetes specialist, highlights the particularly critical condition of approximately 2,500 children in Gaza living with Type 1 diabetes. The convergence of insulin shortages, inadequate storage conditions, and persistent power outages is creating a severe crisis. Dr. al-Ghouti warns that the deterioration of insulin quality, the expiration of existing stock, and improper storage can significantly reduce its effectiveness. This can create a false sense of security, as blood sugar levels may remain uncontrolled despite medication, potentially leading to life-threatening emergencies such as diabetic ketoacidosis.

"Taking an expired dose of insulin may cause significant harm inside the body, while giving a temporary impression of improvement," Dr. al-Ghouti explained. For diabetes patients in Gaza, the condition is no longer simply manageable. Between the scarcity of insulin, the lack of essential testing tools, escalating prices, and deteriorating nutritional circumstances, even the most fundamental aspects of treatment have become an overwhelming daily struggle for survival.

Source: Original Article